P/B
0,3
Tilray Brands
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
$563.9M
Market Cap • 9/14/2026
2011
(15 years)
Founded
2015
(11 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,6
P/EBITDA
123,3
P/OCF
—
P/FCF
—
P/E
—
BVPS
14,4
EPS
—
Market Cap
Market Cap
563,9M
EV
711,6M
EV/Revenue
0,8
EV/EBITDA
155,6
EV/EBIT
-11,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-28,4%
Total Yield
-28,4%
Dividend Yield 5Y
0%
Payout
0%
Retained Earnings
-5B
Profitability
Gross Margin
28,4%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
428,2%
R&D/Revenue
0%
Capex/Revenue
3,6%
Capex/D&A
48,8%
Capex/OCF
-47,7%
SBC/OCF
—
% PPE
31%
% Goodwill
32,3%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
12,3%
CAGR Op. Income 5Y
-13,8%
CAGR Net Income 5Y
-20,7%
CAGR EPS 5Y
-39,6%
CAGR OCF 5Y
9,1%
Leverage
N.D./EBITDA
36,5
Debt/Equity
0%
Current Ratio
2,2
Quick Ratio
1,2
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!